271 related articles for article (PubMed ID: 2071994)
1. Quantitative relationship between anti-PGL-I-specific antibody levels and the lepromin reaction.
David HL; Maroja M F; Cruaud P
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):332-4. PubMed ID: 2071994
[No Abstract] [Full Text] [Related]
2. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of anti-PGL-1, anti-35 kDa and anti-lipoarabinomannan assays for serodiagnosis of leprosy.
Jayapal V; Selvibai G; Mahalakshmi K; Pushkala ; Regunath K; Subramanian S
Indian J Lepr; 2001; 73(3):229-37. PubMed ID: 11840595
[TBL] [Abstract][Full Text] [Related]
4. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
[TBL] [Abstract][Full Text] [Related]
5. Ability of the phenolic glycolipid-I antigen of M. leprae to elicit a positive Mitsuda response in the armadillo (Dasypus novemcinctus).
Job CK; Sanchez RM; McCormick GT; Hastings RC
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):299-304. PubMed ID: 3298476
[TBL] [Abstract][Full Text] [Related]
6. Filter paper blood spot test for detection of anti-ND-BSA antibodies in school children.
Sahasrabudhe R; Dandekar S; Shah DH; Naik S; Ganapathi R
Indian J Med Res; 1992 May; 95():105-11. PubMed ID: 1506059
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae.
Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS
FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167
[TBL] [Abstract][Full Text] [Related]
8. A serologic study of naturally acquired leprosy in chimpanzees.
Gormus BJ; Xu KY; Alford PL; Lee DR; Hubbard GB; Eichberg JW; Meyers WM
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):450-7. PubMed ID: 1890369
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
10. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
[TBL] [Abstract][Full Text] [Related]
11. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of leprosy in the nine-banded armadillo and the significance of IgM antibodies to PGL-1.
Job CK; Drain V; Truman R; Deming AT; Sanchez RM; Hastings RC
Indian J Lepr; 1992; 64(2):137-51. PubMed ID: 1607712
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of the incidence of leprosy in a hyperendemic area in Zaire, with special reference to PGL-antibody results. The Yalisombo Study Group.
Groenen G; Pattyn SR; Ghys P; Tshilumba K; Kuykens L; Colston MJ
Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):641-50. PubMed ID: 2280114
[TBL] [Abstract][Full Text] [Related]
14. The contribution of serological tests to leprosy control.
Klatser PR; Cho SN; Brennan PJ
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S63-6; discussion S66-7. PubMed ID: 9030128
[No Abstract] [Full Text] [Related]
15. Serodiagnosis of leprosy with PGL-1 using ELISA technique.
Dandekar SR; Shah DH; Naik SS; Ganapathi R
Indian J Med Res; 1987 Jun; 85():597-603. PubMed ID: 3315988
[No Abstract] [Full Text] [Related]
16. Delayed hypersensitivity skin reactions to lepromin and antigens prepared from four other mycobacteria.
Govil DC; Bhutani LK
Lepr India; 1978 Oct; 50(4):550-4. PubMed ID: 374872
[No Abstract] [Full Text] [Related]
17. Enhanced response of serum IgG class of anti-PGL-I antibodies in leprosy patients during onset and following clinical remission of type 1 and type 2 reactions.
Saha K; Chattopadhya D; Kashyup A; Agarwal U; Chakrabarty AK
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):105-9. PubMed ID: 7730708
[No Abstract] [Full Text] [Related]
18. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
[TBL] [Abstract][Full Text] [Related]
19. Detection of Mycobacterium leprae infection employing a combinatorial approach of anti-45 kDa and modified anti-PGL-I antibody detection assays.
Parkash O; Kumar A; Pandey R; Franken KLMC; Ottenhoff THM
J Med Microbiol; 2007 Aug; 56(Pt 8):1129-1130. PubMed ID: 17644727
[No Abstract] [Full Text] [Related]
20. Immunological profile of treated lepromatous leprosy patients.
Joshi B; Girdhar BK; Mohanty KK; Beuria MK; Girdhar A; Sengupta U
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):195-203. PubMed ID: 11875763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
